Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Memorial Sloan Kettering Cancer Center · New York University · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
560
total citations
- FWCI
- 21.42
- Percentile
- 100%
- References
- 18
Citations per year
Authors
19- ZYZhan YaoCorresponding
Memorial Sloan Kettering Cancer Center
- RYRona Yaeger
Memorial Sloan Kettering Cancer Center
- VRVanessa Rodrik-Outmezguine
Memorial Sloan Kettering Cancer Center
- ATAnthony Tao
New York University, New York College of Health Professions
- NMNeilawattie M. Torres
Memorial Sloan Kettering Cancer Center
Topics & keywords
Topics
Keywords
- Mutant
- Kinase
- MAPK/ERK pathway
- Protein kinase A
- Biology
- Wild type
- GTP'
- Signal transduction
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.